ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Session » Systemic Sclerosis, Fibrosing Syndromes, and Raynaud's – Clinical Aspects and Therapeutics - Poster II

Date: Monday, November 14, 2016

Time: 9:00AM-11:00AM

Meeting: 2016 ACR/ARHP Annual Meeting

9:00AM-11:00AM
Abstract Number: 1880
A Large Proportion of Patients in an Early Systemic Sclerosis-Associated Interstitial Lung Disease Cohort Have Coexisting Pulmonary Hypertension
9:00AM-11:00AM
Abstract Number: 1867
An Abnormal Nailfold Capillaroscopy Pattern Is Common in Patients with Connective Tissue Disease and Is Associated with Pulmonary and Oesophageal Involvement, Even in the Absence of Systemic Sclerosis
9:00AM-11:00AM
Abstract Number: 1900
Anti-Topoisomerase Positive Systemic Sclerosis – Prognosis Infaust?
9:00AM-11:00AM
Abstract Number: 1885
Can Nailfold Videocapillaroscopy Images be Interpreted Reliably By Different Observers? Results of an Inter-Reader and Intra-Reader Exercise Among Rheumatologists with Different Experience in This Field
9:00AM-11:00AM
Abstract Number: 1877
Confirmatory Factor Analysis and Assessment of Differential Item Functioning of the Satisfaction with Appearance Scale in Systemic Sclerosis: A Comparison Across Sex, Race/Ethnicity and Disease Subtype
9:00AM-11:00AM
Abstract Number: 1902
Detecting the Pulmonary Vascular Involvement and the Changes in Gene Activation Profiles at Early Stage of Systemic Sclerosis in Patients with Raynaud Phenomenon
9:00AM-11:00AM
Abstract Number: 1903
Determining Disease Course in Localized Scleroderma: A Prospective Cohort Study
9:00AM-11:00AM
Abstract Number: 1896
Efficacy of Pulmonary Arterial Hypertension-Specific Drugs Combination Therapy in Survival of Patients with Pulmonary Arterial Hypertension Associated with Systemic Sclerosis and Other Connective Tissue Diseases
9:00AM-11:00AM
Abstract Number: 1884
Esophageal Dilation and Interstitial Lung Disease Incidence and Progression in Systemic Sclerosis
9:00AM-11:00AM
Abstract Number: 1891
Excellent Reliability of Semiquantitative Nailfold Capillaroscopy Assessment in a Systemic Sclerosis Cohort – a Pilot Study
9:00AM-11:00AM
Abstract Number: 1883
Exercise Habits and Factors Associated with Exercise in Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network (SPIN) Cohort Study
9:00AM-11:00AM
Abstract Number: 1870
First Pilot Study of an Implantable Loop Recorder (ILR) in Systemic Sclerosis Detects Significant Cardiac Arrhythmias with CMR Abnormalities
9:00AM-11:00AM
Abstract Number: 1890
Functional Disability and Its Predictors in Systemic Sclerosis: A Study from the Desscipher Project within the European Scleroderma Trials and Research Group
9:00AM-11:00AM
Abstract Number: 1892
Immunosignature Technology Differentiates Patients with Systemic Sclerosis and Internal Organ Involvement
9:00AM-11:00AM
Abstract Number: 1895
Increased CXCL4/PF4 Presence in Systemic Sclerosis and Absence of Heparin Directed Autoantibodies
9:00AM-11:00AM
Abstract Number: 1894
Increased Mortality in Systemic Sclerosis Patients with Fibrosing Myopathy
9:00AM-11:00AM
Abstract Number: 1873
Longitudinal Analysis of Modified Rodnan Skin Score in Systemic Sclerosis Using Group-Based Trajectory Modelling
9:00AM-11:00AM
Abstract Number: 1874
Low Rate of Progression in Cases of Isolated Raynaud’s Phenomenon Screened By Nailfold Videocapillaroscopy and Antinuclear Antibody Status Supports Negative Predictive Value of These Tests
9:00AM-11:00AM
Abstract Number: 1869
Mental Health Care in Systemic Sclerosis; Rates of Utilization and Associated Factors in the Scleroderma Patient-Centered Intervention Network Cohort
9:00AM-11:00AM
Abstract Number: 1887
Olfactory Impairment Is Associate with Cognitive Dysfunction and Regional Brain Atrophy in Systemic Sclerosis
9:00AM-11:00AM
Abstract Number: 1875
Physical Activity in Patients with Systemic Sclerosis
9:00AM-11:00AM
Abstract Number: 1871
Predicting Vascular Complications in Systemic Sclerosis: A Prospective Cohort Study
9:00AM-11:00AM
Abstract Number: 1889
Predictors of Acro-Osteolysis in Systemic Sclerosis
9:00AM-11:00AM
Abstract Number: 1882
Predictors of Response to Methotrexate in Patients with Eosinophilic Fasciitis (Shulman’s Disease)
9:00AM-11:00AM
Abstract Number: 1876
Prevalence of Anti-RNA Polymerase III IgG Antibody in a Cohort of Patients with Delayed Wound Healing
9:00AM-11:00AM
Abstract Number: 1893
Prevalence of Antiphospholipid Antibodies in Systemic Sclerosis: A Systematic Review and Meta-Analysis
9:00AM-11:00AM
Abstract Number: 1868
Rates and Predictors of Physical Therapy and Occupational Therapy Utilization in Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network Cohort Study
9:00AM-11:00AM
Abstract Number: 1888
Reliability, Validity, and Sensitivity to Change of the Simplified Duruoz Hand Index in Systemic Sclerosis
9:00AM-11:00AM
Abstract Number: 1886
Right Ventricular Load-Adaptability and Response to Therapy in Scleroderma Versus Idiopathic Pulmonary Arterial Hypertension
9:00AM-11:00AM
Abstract Number: 1901
Screening for Pulmonary Arterial Hypertension in an Unselected Prospective Systemic Sclerosis Cohort
9:00AM-11:00AM
Abstract Number: 1878
Speckle Tracking Echocardiography: A Sensitive Technique for Detecting Early Left Ventricular Dysfunction in Patients with Systemic Sclerosis
9:00AM-11:00AM
Abstract Number: 1881
Targeting Oncostatin M in the Target Tissue: Assessment of in-Vivo Affinity and Target Engagement of an Anti-OSM Monoclonal Antibody By Combining Blood and Skin Blister Fluid Data
9:00AM-11:00AM
Abstract Number: 1879
The Correlation Between Oxidized Low-Density Lipoprotein and Clinical Manifestations in Patients with Systemic Sclerosis
9:00AM-11:00AM
Abstract Number: 1872
The Effect of Cyclophosphamide on Pulmonary Function and Dependence on Disease Activity of Interstitial Lung Disease Associated with Systemic Sclerosis
9:00AM-11:00AM
Abstract Number: 1899
The Intestinal Involvement in Systemic Sclerosis Is Characterized By a Peculiar Gut Microbiota
9:00AM-11:00AM
Abstract Number: 1898
The Lack of Association of Osteoporosis with Proton Pump Inhibitor in Scleroderma: A UK Single Centre Cohort Experience
9:00AM-11:00AM
Abstract Number: 1897
Vitamin-D Levels and Gastrointestinal (GI) Manifestations in Systemic Sclerosis (SSc)

« View all sessions from this meeting

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology